Card paper

ПРОДУКТ КОН'ЮГУВАННЯ ЦИТОКІНУ ДЛЯ ВИКОРИСТАННЯ У ПРОТИРАКОВІЙ ТЕРАПІЇ

ibliography

Патент України (на 20 р.)
not available
(51)
IPC
C07K 14/525 (2006.01)
C07K 14/57 (2006.01)
C07K 16/30 (2006.01)
C07K 19/00 (2006.01)
C12N 15/23 (2006.01)
C12N 15/28 (2006.01)
C12N 15/62 (2006.01)
A61K 38/19 (2006.01)
A61K 38/21 (2006.01)
A61K 48/00 (2006.01)
A61K 31/7105 (2006.01)
A61P 35/00 (2006.01)
(11)
85365
(22)
13.02.2001
(24)
26.01.2009
(21)
2002097447
(31)
MI2000A000249
(32)
15.02.2000
(33)
IT
(41)
16.12.2002, бюл. № 12
(46)
26.01.2009, бюл. № 2
(56)
WO 9913329 A, 18.03.1999
WO 9810795 A, 19.03.1998
ARAP W ET AL: "CANCER TREATMENT BY TARGETED DRUG DELIVERY TO TUMOR VASCULATURE IN A MOUSE MODEL" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 279, 16 January 1998 (1998-01-16), pages 377-380, XP000857470 ISSN: 0036-8075
PASQUALINI RENATA ET AL: "Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis." CANCER RESEARCH, vol. 60, no. 3, 1 February 2000 (2000-02-01), pages 722-727, XP002180667 ISSN: 0008-5472
A. GASPARRI ET AL: "Tumor pretargeting with avidin improves the therapeutic index of biotinylated Tumor Necrosis Factor alpha in mouse models" CANCER RESEARCH., vol. 59, 15 June 1999 (1999-06-15), pages 2917-2923, XP002180668 MD US
MORO M ET AL: "TUMOR CELL TARGETING WITH ANTIBODY-AVIDIN COMPLEXES AND BIOTINYLATED TUMOR NECROSIS FACTOR ALPHA1" CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 57, no. 10, 15 May 1997 (1997-05-15), pages 1922-1928, XP000764022 ISSN: 0008-5472
YANG J ET AL: "A GENETICALLY ENGINEERD SINGLE-CHAIN FV/TNF MOLECULE POSSESSES THE ANTI-TUMOR IMMUNOREACTIVITY OF FV AS WELL AS THE CYTOTOXIC ACTIVITY OF TUMOR NECROSIS FACTOR" MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, vol. 32, no. 12, 1 August 1995 (1995-08-01), pages 873-881, XP000653177 ISSN: 0161-5890
A. CORTI ET AL: "Tumor targeting with biotinylated Tumor Necrosis factpor alpha: Structure-Acitivity relationship and mechanism of action on avidin pretargeted tumor cells." CANCER RESEARCH., vol. 58, 1 September 1998 (1998-09-01), pages 3866-3872, XP002180669 MD US
CHEN WANG-QIU ET AL: "Enhanced anti-tumor effect of an IFN-gamma-EGF fusion protein." BIOMEDICAL AND ENVIRONMENTAL SCIENCES, vol. 10, no. 4, December 1997 (1997-12), pages 387-395, XP001030801 ISSN: 0895-3988
PAGANELLI G.ET AL: "clinical application of the avidin/biotin system for tumor targeting pp.239-253" 1995 , IN D. GOLDENBERG (ED. CANCER THERAPY WITH RADIOLABELED ANTIBODIES. CRC PRESS, BOCA RATON, XP001033462
CURNIS FLAVIO ET AL: "Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)." NATURE BIOTECHNOLOGY, vol. 18, no. 11, November 2000 (2000-11), pages 1185-1190, XP002180671 ISSN: 1087-0156
CURNIS FLAVIO ET AL: "Targeted delivery of tumor necrosis factor alpha (TNF) to tumor associated vessels." INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, vol. 6, no. Supplement 1, 19 - 21 October 2000, page S72 XP001030678 Joint Meeting of the 5th World Congress on Advances in Oncology and the 3rd International Symposium on Molecular Medicine;Crete, Greece; October 19-21, 2000 ISSN: 1107-3756
(85)
15.09.2002
(86)
PCT/EP01/01543, 13.02.2001
(71)
ФОНДАЦІОНЕ ЧЕНТРО САН РАФФАЕЛЄ ДЕЛЬ МОНТЕ ТАБОР IT
 
ФОНДАЦИОНЕ ЧЕНТРО САН РАФФАЭЛЕ ДЕЛЬ МОНТЕ ТАБОР IT
 
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR IT
(72)
Корті Анджело IT
 
Корти Анджело IT
 
Corti Angelo IT
(73)
ОСПЕДАЛЄ САН РАФАЕЛЄ С.Р.Л. IT
(74)
Мошинська Ніна Миколаївна
(98)
Патентний повірений Мошинська Ніна Миколаївна
Юридична фірма "Городисський та партнери", вул. В. Чорновола, 25, офіс 3, м. Київ, 01135
UA
Formula

Abstract (UK)

Abstract (RU)

Abstract (EN)

Description